We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$148B
AUM Growth
-$29.6B
Cap. Flow
+$309M
Cap. Flow %
0.21%
Top 10 Hldgs %
25.25%
Holding
2,853
New
162
Increased
982
Reduced
855
Closed
113

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$166M
2
TSLA icon
Tesla
TSLA
+$92.9M
3
RBLX icon
Roblox
RBLX
+$51.2M
4
VICI icon
VICI Properties
VICI
+$42.8M
5
DHR icon
Danaher
DHR
+$42.2M

Sector Composition

Rank Sector Weight
1 Technology 26.43%
2 Healthcare 15.87%
3 Consumer Discretionary 11.68%
4 Communication Services 8.96%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIC icon
2776
Oric Pharmaceuticals
ORIC
$1.42B
-60,600
Closed -$324K
ORMP icon
2777
Oramed Pharmaceuticals
ORMP
$181M
-85,500
Closed -$740K
PASG icon
2778
Passage Bio
PASG
$14.6M
-2,975
Closed -$184K
PLRX icon
2779
Pliant Therapeutics
PLRX
$65M
-29,800
Closed -$209K
PRLD icon
2780
Prelude Therapeutics
PRLD
$451M
-29,700
Closed -$205K
PSNL icon
2781
Personalis
PSNL
$1.49B
-79,500
Closed -$651K
QNCX icon
2782
Quince Therapeutics
QNCX
$31.3M
-179
Closed -$222K
REKR icon
2783
Rekor Systems
REKR
$96.7M
-83,200
Closed -$379K
RSKD icon
2784
Riskified
RSKD
$780M
-53,000
Closed -$320K
SGHT icon
2785
Sight Sciences
SGHT
$442M
-28,000
Closed -$324K
SKYT
2786
DELISTED
SkyWater Technology
SKYT
-21,500
Closed -$233K
SPIR icon
2787
Spire Global
SPIR
$571M
-12,875
Closed -$216K
SPRU icon
2788
Spruce Power Holding Corp
SPRU
$39.5M
-30,913
Closed -$492K
STRO icon
2789
Sutro Biopharma
STRO
$307M
-7,660
Closed -$630K
STTK icon
2790
Shattuck Labs
STTK
$781M
-32,200
Closed -$137K
TCRT icon
2791
Alaunos Therapeutics
TCRT
$4.66M
-3,407
Closed -$333K
TSHA icon
2792
Taysha Gene Therapies
TSHA
$2.04B
-41,000
Closed -$267K
URGN icon
2793
UroGen Pharma
URGN
$2.36B
-47,900
Closed -$417K
VKTX icon
2794
Viking Therapeutics
VKTX
$4.01B
-166,500
Closed -$500K
VRM icon
2795
Vroom Inc
VRM
$52.3M
-2,024
Closed -$431K
WPRT
2796
Westport Fuel Systems
WPRT
$35.3M
-34,550
Closed -$555K
XBIT icon
2797
XBiotech
XBIT
$69.8M
-46,800
Closed -$404K
ZG icon
2798
Zillow
ZG
$7.43B
-265,869
Closed -$12.8M
ZYME icon
2799
Zymeworks
ZYME
$1.74B
-118,500
Closed -$776K
ZYXI
2800
DELISTED
Zynex
ZYXI
-54,310
Closed -$338K

Similar funds

Swiss National Bank's Q2 2022 Portfolio in Review

As of Q2 2022, Swiss National Bank held 2,853 positions worth $148B, down 17% from $177B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Swiss National Bank's Q2 2022 filing shows 162 new, 982 increased, 855 reduced and 113 closed positions. Its largest new stake was Roblox: 1,524,500 shares worth $50.1M. The largest sale was AT&T, an estimated $199M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q2 2022 buy was Roblox: 1,524,500 shares worth $50.1M.
  • Swiss National Bank added most to Warner Bros in Q2 2022, an estimated $166M increase.
  • Swiss National Bank's biggest Q2 2022 reduction was AT&T, cutting an estimated $199M.
  • Swiss National Bank fully exited Cerner Corp in Q2 2022, selling an estimated $119M.
  • Swiss National Bank's ten largest holdings make up 25% of its $148B portfolio in Q2 2022.
  • Swiss National Bank opened 162 new positions and closed 113 in Q2 2022.
  • Swiss National Bank's portfolio value fell 17% quarter-over-quarter to $148B.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.